A. What is the PLASMIC Score?

The **PLASMIC score calculator** is a clinical prediction tool used to estimate the likelihood of severe ADAMTS13 deficiency in adult patients presenting with suspected Thrombotic Thrombocytopenic Purpura (TTP). TTP is a rare but life-threatening blood disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage, primarily due to widespread small blood clots. Severe ADAMTS13 deficiency (<10% activity) is the hallmark of acquired TTP.

This score helps clinicians rapidly assess the probability of severe ADAMTS13 deficiency at presentation, guiding urgent treatment decisions such as plasma exchange, even before confirmatory ADAMTS13 activity results are available. Early intervention is crucial for improving patient outcomes in TTP.

Who should use it? The PLASMIC score is primarily intended for healthcare professionals (physicians, nurses, residents) in emergency departments, intensive care units, and hematology services who are evaluating patients with suspected TTP. It is a valuable tool for risk stratification and decision-making regarding immediate management strategies.

Common misunderstandings: It's important to understand that the PLASMIC score is a predictive tool for ADAMTS13 deficiency, not a definitive diagnostic test for TTP itself. A high score suggests a high probability of severe deficiency, warranting presumptive treatment for TTP. Conversely, a low score suggests a lower probability, prompting consideration of other diagnoses that mimic TTP (e.g., atypical hemolytic uremic syndrome, disseminated intravascular coagulation, severe sepsis). The score does not account for all possible factors and should always be used in conjunction with clinical judgment and other diagnostic investigations.

B. PLASMIC Score Formula and Explanation

The **PLASMIC score calculator** is an unweighted, additive scoring system. Each of the seven criteria, when present, contributes one point to the total score. The maximum possible score is 7.

The criteria are:

1. Platelet count < 30,000/µL
2. Lytic hemolysis (evidence of red blood cell destruction, e.g., elevated LDH, indirect bilirubin, reticulocytosis, undetectable haptoglobin)
3. Active cancer (excluding solid tumor in remission or non-melanoma skin cancer)
4. Solid organ or hematopoietic stem cell transplant
5. Mean Corpuscular Volume (MCV) < 90 fL
6. INR < 1.5
7. Creatinine > 2.0 mg/dL (or > 177 µmol/L)

The total score obtained from the **PLASMIC score calculator** is then used to stratify patients into low, intermediate, or high-risk categories for severe ADAMTS13 deficiency.

Variables Table for PLASMIC Score Criteria

C. Practical Examples Using the PLASMIC Score Calculator

Let's walk through a couple of examples to demonstrate how to use the **PLASMIC score calculator** and interpret its results.

Example 1: High-Risk Scenario

A 45-year-old patient presents with severe fatigue, neurological changes, and lab results showing:

• Platelet count: 20,000/µL (< 30,000/µL: Yes)
• LDH: 1200 U/L (elevated, indicating Hemolysis: Yes)
• No known active cancer (Active Cancer: No)
• No history of transplant (Transplant: No)
• MCV: 85 fL (< 90 fL: Yes)
• Creatinine: 2.5 mg/dL (> 2.0 mg/dL: Yes)
• INR: 1.1 (< 1.5: Yes)

Inputs: Platelet < 30k (Yes), Hemolysis (Yes), Active Cancer (No), Transplant (No), MCV < 90 (Yes), Creatinine > 2.0 (Yes), INR < 1.5 (Yes).

Result: 5 points. This places the patient in the Intermediate-risk category for severe ADAMTS13 deficiency. This score suggests a significant likelihood of TTP, and clinicians would likely initiate plasma exchange while awaiting ADAMTS13 activity results.

Example 2: Low-Risk Scenario

A 60-year-old patient with pneumonia presents with some microangiopathic hemolytic anemia and thrombocytopenia. Lab results show:

• Platelet count: 80,000/µL (< 30,000/µL: No)
• LDH: 400 U/L (elevated, indicating Hemolysis: Yes)
• Active lung cancer (Active Cancer: Yes)
• No history of transplant (Transplant: No)
• MCV: 92 fL (< 90 fL: No)
• Creatinine: 1.0 mg/dL (> 2.0 mg/dL: No)
• INR: 1.8 (< 1.5: No)

Inputs: Platelet < 30k (No), Hemolysis (Yes), Active Cancer (Yes), Transplant (No), MCV < 90 (No), Creatinine > 2.0 (No), INR < 1.5 (No).

Result: 2 points. This places the patient in the Low-risk category for severe ADAMTS13 deficiency. While the patient has some features of TTP, the low PLASMIC score suggests that another diagnosis, such as cancer-associated TMA or sepsis, is more likely. ADAMTS13 testing would still be pursued, but immediate empiric TTP treatment might be deferred in favor of further investigation into other causes.

D. How to Use This PLASMIC Score Calculator

Our online **PLASMIC score calculator** is designed for ease of use and quick assessment. Follow these simple steps:

1. Review Each Criterion: For each of the seven criteria listed, carefully evaluate your patient's clinical presentation and laboratory results.
2. Select "Yes" or "No": Based on your assessment, select "Yes" if the criterion is met, and "No" if it is not. The helper text below each input provides additional context and relevant units or thresholds (e.g., platelet count < 30,000/µL, creatinine > 2.0 mg/dL).
3. Automatic Calculation: The calculator updates the score in real-time as you make your selections. You can also click the "Calculate Score" button to manually trigger an update.
4. Interpret Results: The primary result will display the total PLASMIC score (0-7), followed by its corresponding risk category (Low, Intermediate, High) and a brief interpretation of the risk for severe ADAMTS13 deficiency.
5. Copy Results: Use the "Copy Results" button to quickly copy the score and interpretation for documentation or sharing.
6. Reset: If you need to start over, click the "Reset" button to clear all selections and revert to default values.

How to select correct units: The PLASMIC score criteria are based on specific thresholds. This calculator simplifies input by asking "Yes/No" if a criterion (which includes its unit and threshold) is met. Therefore, you don't need to select units; you simply need to ensure your patient's lab values are interpreted against the stated thresholds and units (e.g., mg/dL for creatinine, fL for MCV).

How to interpret results:

• Score 0-4: Low Probability of severe ADAMTS13 deficiency (<20%). While TTP is less likely, other thrombotic microangiopathies or conditions mimicking TTP should be considered.
• Score 5: Intermediate Probability of severe ADAMTS13 deficiency (approx. 50%). This is a grey zone, and a strong suspicion for TTP may still warrant initiation of treatment while awaiting definitive ADAMTS13 results.
• Score 6-7: High Probability of severe ADAMTS13 deficiency (>80%). Empiric treatment for TTP (e.g., plasma exchange) is strongly recommended, even before ADAMTS13 activity levels are confirmed.

E. Key Factors That Affect the PLASMIC Score

Each of the seven criteria in the **PLASMIC score calculator** plays a specific role in predicting severe ADAMTS13 deficiency. Understanding these factors helps in appreciating the clinical utility of the score:

• Platelet count < 30,000/µL: This is a strong indicator of severe thrombocytopenia, a hallmark of TTP. While other conditions can cause low platelets, this specific threshold points towards the severity seen in TTP.
• Evidence of Hemolysis: Microangiopathic hemolytic anemia (MAHA) is another cardinal feature of TTP, resulting from red blood cells being sheared as they pass through fibrin-rich microthrombi. Elevated LDH, indirect bilirubin, reticulocytosis, and undetectable haptoglobin are all laboratory markers reflecting this process.
• Active Cancer: While cancer itself can cause thrombotic microangiopathies, TTP is less common in the context of active malignancy. Its presence reduces the likelihood of severe ADAMTS13 deficiency, suggesting other TMA etiologies.
• Solid Organ or Hematopoietic Stem Cell Transplant: Similar to active cancer, a history of transplant often points towards other forms of TMA, such as calcineurin inhibitor-induced TMA or post-transplant TMA, rather than idiopathic TTP with severe ADAMTS13 deficiency.
• Mean Corpuscular Volume (MCV) < 90 fL: A low MCV (microcytosis) is not a typical feature of TTP. Its presence suggests other underlying conditions (e.g., iron deficiency anemia, thalassemia) that might be contributing to or mimicking the patient's symptoms, thus making severe ADAMTS13 deficiency less likely.
• Creatinine > 2.0 mg/dL: Significant renal impairment is more characteristic of other thrombotic microangiopathies like hemolytic uremic syndrome (HUS) or atypical HUS (aHUS) than TTP. While TTP can involve the kidneys, severe renal dysfunction usually points away from severe ADAMTS13 deficiency. The unit mg/dL is commonly used in the US, with µmol/L being the equivalent in many other regions.
• INR < 1.5: A normal or near-normal INR (International Normalized Ratio) indicates that the patient does not have a significant underlying coagulopathy. TTP is a disorder of platelet aggregation and microthrombi formation, not typically associated with widespread activation of the coagulation cascade that would prolong INR. A prolonged INR would suggest conditions like DIC, which can mimic TTP.

Collectively, these factors help distinguish TTP from other conditions with similar presentations, making the **PLASMIC score calculator** an invaluable tool for initial assessment.

F. Frequently Asked Questions (FAQ) about the PLASMIC Score

Q1: What does a high PLASMIC score mean?

A high PLASMIC score (6-7 points) suggests a high probability (>80%) of severe ADAMTS13 deficiency, which is characteristic of acquired Thrombotic Thrombocytopenic Purpura (TTP). In such cases, empiric treatment with plasma exchange is often initiated while awaiting definitive ADAMTS13 activity results.

Q2: Can the PLASMIC score rule out TTP?

A low PLASMIC score (0-4 points) indicates a low probability (<20%) of severe ADAMTS13 deficiency. While it significantly reduces the likelihood of TTP, it does not completely rule it out. Other diagnoses that mimic TTP should be strongly considered and investigated.

Q3: Are there any specific units I need to be aware of when using this PLASMIC score calculator?

Yes. The criteria for the PLASMIC score are based on specific lab units and thresholds. For instance, platelet count is in /µL, MCV in fL, creatinine in mg/dL (or µmol/L equivalent), and INR is a unitless ratio. Our calculator explicitly states these units and thresholds in the input labels and helper texts to ensure accurate interpretation of your patient's lab values.

Q4: How quickly should I get ADAMTS13 results after using the PLASMIC score?

ADAMTS13 activity testing can take several days, which is why the PLASMIC score is so valuable for initial risk stratification. Even with a high PLASMIC score, ADAMTS13 activity levels are crucial for definitive diagnosis and long-term management decisions.

Q5: Is the PLASMIC score used for pediatric patients?

The PLASMIC score was validated in adult patients. Its applicability to pediatric populations is less clear, and other diagnostic approaches might be more appropriate for children with suspected TTP or other thrombotic microangiopathies.

Q6: What if some of the lab values are borderline?

The PLASMIC score uses strict thresholds (e.g., <30,000/µL, >2.0 mg/dL). If a value is borderline (e.g., platelet count 31,000/µL), it technically falls outside the "Yes" criterion. Clinical judgment is always paramount. In such ambiguous cases, a lower score might prompt more aggressive investigation into alternative diagnoses, or a higher index of suspicion for TTP might still warrant early treatment initiation, particularly if other clinical features are strongly suggestive.

Q7: Does the PLASMIC score replace clinical judgment?

Absolutely not. The PLASMIC score is a powerful clinical decision support tool, but it should always be used in conjunction with a thorough clinical assessment, patient history, physical examination, and other relevant laboratory and imaging studies. It aids in risk stratification but does not replace the expertise of a medical professional.

Q8: Can other conditions cause a high PLASMIC score?

While a high PLASMIC score strongly suggests severe ADAMTS13 deficiency, other conditions can sometimes mimic components of the score. For example, severe sepsis can cause thrombocytopenia and hemolysis, and certain renal diseases elevate creatinine. However, the combination of multiple criteria in the PLASMIC score is highly specific for TTP.